Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005.
NIST and the National Cancer Institute cosponsored a workshop on August 18-19, 2005, to examine needs for reference materials for early cancer detection. This meeting focused on standards, methods, assays, reagents, and technologies. Needs for plasma and serum proteomics, DNA methylation, and specimen reference collections were discussed, and recommendations from participants were solicited. This report summarizes the discussion and recommendations for proteomics reference materials.
Barker
Peter E
PE
NIST-National Cancer Institute Cancer Biomarker Reference Laboratory, NIST Mass Spectrometry Data Center, Analytical Chemistry Division, NIST, Gaithersburg, MD 20899-8311, USA.
Wagner
Paul D
PD
Stein
Stephen E
SE
Bunk
David M
DM
Srivastava
Sudhir
S
Omenn
Gilbert S
GS
D014408:Biomarkers, Tumor / Q000097:blood / Q000592:standards*; D001798:Blood Proteins / Q000032:analysis / Q000592:standards*; D019175:DNA Methylation; D042241:Early Diagnosis; D006801:Humans; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000175:diagnosis*; D010949:Plasma; D040901:Proteomics / Q000592:standards*; D012015:Reference Standards; D044967:Serum; D014481:United States
D014408:Biomarkers, Tumor; D001798:Blood Proteins